Abstract
ObjectivesLittle is known about how workers use cannabis following a work-related injury/illness, including whether they receive clinical guidance. The objective was to compare characteristics of workers using and not using cannabis after a work-related injury/illness and describe use patterns.DesignCross-sectional study.Setting and participantsWorkers who experienced a work-related physical injury/illness resulting in one or more days of lost time compensated by the workers’ compensation authority in Ontario, Canada (n=1196).MethodsParticipants were interviewed 18 or 36 months after their injury/illness. Participants were asked about their past-year cannabis use, including whether use was for the treatment of their work-related condition. Sociodemographic, work and health characteristics were compared across cannabis groups: no past-year use; use for the work-related condition; use unrelated to the work-related condition. Cannabis use reasons, patterns, perceived impact and healthcare provider engagement were described.ResultsIn total, 27.4% of the sample reported using cannabis (14.1% for their work-related condition). Workers using cannabis for their condition were less likely to be working (58.0%) and more likely to have quite a bit/extreme pain interference (48.5%), psychological distress (26.0%) and sleep problems most/all the time (62.1%) compared with those not using cannabis (74.3%, 26.3%, 12.0% and 38.0%, respectively) and those using cannabis for other reasons (74.2%, 19.5%, 12.0% and 37.1%, respectively) (all p<0.0001). No significant differences were observed in medical authorisations for use among those using cannabis for their condition (20.4%) or unrelated to their condition (15.7%) (p=0.3021). Healthcare provider guidance was more common among those using cannabis for their condition (32.7%) compared with those using for other reasons (17.1%) (p=0.0024); however, two-thirds of this group did not receive guidance.ConclusionsCannabis may be used to manage the consequences of work-related injuries/illnesses, yet most do not receive clinical guidance. It is important that healthcare providers speak with injured workers about their cannabis use.
Funder
Canadian Institutes of Health Research
Workplace Safety and Insurance Board
Reference69 articles.
1. UNODC . World drug report 2022. United Nations publication, sales No.22.XI.8; 2022. Available: https://www.unodc.org/unodc/data-and-analysis/world-drug-report-2022.html
2. Looking back from 2020, how cannabis use and related behaviours changed in Canada;Rotermann;Health Rep,2021
3. Substance Abuse and Mental Health Services Administration . Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health. Report No.: HHS Publication No.PEP22-07-01-005, NSDUH Series H-57. Rockville, MD, 2022. Available: https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
4. Cannabis surveillance with Twitter data: emerging topics and social bots;Allem;Am J Public Health,2020
5. Leas EC , Nobles AL , Caputi TL , et al . Trends in Internet searches for Cannabidiol (CBD) in the United States. JAMA Netw Open 2019;2:e1913853. doi:10.1001/jamanetworkopen.2019.13853
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献